2026-09-17 → 10-01 Company Bull
OSCR Reaffirms $4.00 EPS by 2027, CFO Says Nearly Doubling CFO reiterates $4.00 EPS by 2027 at Investor Day, nearly doubling from current levels, reinforcing long-term earnings outlook.
D1 -1.1% · +5d -9.7%
› 4 waves of this story2026-09-17 Management sets 2029 targets, outlining mid-term growth and profitability path2026-09-17 BofA maintains Underperform, raises PT to $30, acknowledges margin improvement, flags high ACA growth expectations2026-09-22 Analyst flags strong EPS target, potential upside from Bertolini2026-10-01 CFO reiterates $4.00 EPS by 2027 at Investor Day, nearly doubling from current levels, reinforcing long-term earnings outlook.2026-09-17 → 09-23 Company Bull
Raymond James Reiterates Outperform on OSCR, $42 PT Firm reiterates, views initial selloff as overdone
D1 -1.1% · +5d -9.7%
› 3 waves of this story2026-09-17 8-K filed with Investor Day; guidance raised, medical loss ratio improved2026-09-18 Brokerage upgrade to Buy with higher PT reinforces post-guidance-raise bullish sentiment2026-09-23 Firm reiterates, views initial selloff as overdone2026-09-23 Capital
Oscar Health Director Wittman Sells 25,000 Shares Director sold shares at $32.24 average, while Piper Sandler reiterates $48 PT
D1 -0.5% · +5d +1.0%
2026-09-15 Analyst Bull
OSCR Added to Zacks Rank #1 Strong Buy Growth Stocks List Zacks highlighted OSCR among top growth stocks on Sep 15, indicating increased institutional attention
D1 -4.1% · +5d -5.5%
2026-09-15 Other Bull
OSCR hits highest price since 2021, less than 8% from all-time high Technical breakout draws attention; stock up sharply from lows
D1 -4.1% · +5d -5.5%
2026-09-10 Company Bear
OSCR falls ~5% on industry-wide medical cost pressure CVS cites elevated medical cost growth in managed care, pressuring insurers including UNH and OSCR
D1 +2.6% · +5d -1.8%
2026-09-04 Analyst Bull
OSCR Breaks Above 20-Day and 50-Day Moving Averages, Turning Bullish Technical indicators signal short-term uptrend; multiple traders add to watchlists
D1 +0.0% · +5d +4.8%
2026-09-02 Company
OSCR Membership Jumps 46% to 2.96M, Profitability in Focus Strong membership growth confirmed by multiple sources, but seasonality and utilization keep profitability in question
D1 +1.7% · +5d +7.4%
2026-08-27 Insider selling
Insider selling $18.2M (1) D1 -3.8% · +5d +7.3%
2026-08-25 Other Bull
OSCR Hits 52-Week High, Multiple Traders Turn Bullish Multiple independent sources confirm OSCR's 52-week high, with positive technical and valuation commentary
D1 -2.8% · +5d -3.6%
2026-08-20 Other
OSCR in Spotlight: Financial Strength & AI Adoption Highlighted by Multiple Outlets Independent sources like Investing.com and IBD both mention OSCR's financial strength and AI use, raising visibility without a major new development.
D1 -2.3% · +5d -4.8%
2026-08-17 Other Bull
OSCR weekly candle engulfs 8 weeks, strong technicals TrendSpider and traders note bullish engulfing pattern, reflecting positive sentiment
D1 -3.7% · +5d +0.8%
2026-08-16 Company
OSCR CEO says in talks with Hims CEO referenced Hims talks in interview, related to Lucie marketplace
D1 -3.7% · +5d +0.8%
2026-08-15 Capital Bull
Thrive Capital Discloses Q2 Holdings: $180.9M in OSCR Prominent investor's significant stake signals institutional confidence
D1 -3.7% · +5d +0.8%
2026-08-08 → 08-09 Earnings Bull
Oscar Health Q2 record profit, raises outlook; adds 98.7% first-pass claims accuracy data Q2 call highlights persist; new operational efficiency metric bolsters profitability narrative
D1 -0.8% · +5d +14.0%
› 3 waves of this story2026-08-08 Q2 FCF up 320% YoY to $2.1B; company raises full-year operating outlook2026-08-08 Q2 call confirms record H1 profitability, raises FY outlook on membership growth, pricing discipline, favorable utilization.2026-08-09 Q2 call highlights persist; new operational efficiency metric bolsters profitability narrative2026-08-06 → 08-08 Earnings Bull
OSCR H1 FCF Up 320% YoY to $2.1B Q2 FCF $2.1B, +320% YoY; share price +85% over same period
D1 -11.9% · +5d +16.0%
› 4 waves of this story2026-08-06 Q2 profit $361M, membership up, medical costs ease; FY outlook raised2026-08-06 Q2 EPS $1.10 beat, rev $4.88B, FY guide raised; stock gave back gains2026-08-08 Q2 FCF of $2.1B vs $500M a year ago, reinforcing earnings quality2026-08-08 Q2 FCF $2.1B, +320% YoY; share price +85% over same period2026-07-26 → 08-06 Analyst Bull
OSCR Q2 Earnings Loom; Analyst Flags Potential Up to $236M Positive Risk Adjustment Large call trades; implied earnings move ~10.98%
D1 +0.5% · +5d +8.5%
› 5 waves of this story2026-07-26 Multiple posts cite earnings proximity and management guidance, with risk adjustment upside flagged, increasing event salience2026-08-01 Multiple earnings calendar accounts confirm OSCR reports next week, ahead of Q2 results2026-08-03 Multiple sources mention earnings proximity and ICHRA/ACA opportunity, but no new facts, just repetition2026-08-03 Multiple posts confirm earnings date, no new facts beyond existing event.2026-08-06 Large call trades; implied earnings move ~10.98%2026-08-06 8-K filing
8-K: Item 2.02, Item 9.01 D1 -11.9% · +5d +16.0%
2026-08-06 Earnings
Earnings report 第二季度医疗损失率（MLR）同比改善12个百分点至79.2%，SG&A费用率创纪录低至14.2%，同比下降450个基点。
D1 -11.9% · +5d +16.0%
2026-08-05 Earnings
Earnings report 第二季度医疗损失率（MLR）同比改善12个百分点至79.2%，SG&A费用率创纪录低至14.2%，同比下降450个基点。
D1 -0.9% · +5d -1.7%
2026-08-04 Analyst Bull
OSCR listed in IBD Top 15, stock gains support IBD ranks OSCR among top stocks, another trader opens position above $30, showing bullish technicals.
D1 -1.2% · +5d -7.9%
2026-07-29 Analyst Bull
OSCR Surges 10.8%, Piper Sandler Raises PT to $36 Rally backed by analyst upgrade and investor day announcement, signaling positive momentum.
D1 -2.6% · +5d -1.5%
2026-07-22 Company Bear
OSCR Falls 4.13% to $29.5; Q2 Risk Adjustment, Margins Under Pressure Zacks notes closing drop; SeekingAlpha flags risk adjustment transfer and plan mix pressuring Q2 EPS/margins, two sources confirm.
D1 -4.1% · +5d +3.6%
2026-07-16 Earnings Bull
UNH Beat Sparks Health Insurance Sector Attention UNH beat with lower medical costs, seen as positive read-across for OSCR peers
D1 -5.7% · +5d +0.2%
2026-06-30 Insider selling Bear
Insider selling $17.8M (1) D1 -3.2% · +5d +8.0%
2026-06-29 Insider selling Bear
Insider selling $18.0M (1) D1 -1.1% · +5d +5.7%
2026-06-26 Insider selling Bear
Insider selling $17.3M (1) D1 +3.9% · +5d +5.5%
2026-06-25 Insider selling Bear
Insider selling $17.6M (1) D1 -1.7% · +5d +12.2%
